Cumberland Pharmaceuticals (NASDAQ:CPIX) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a report published on Friday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. Cumberland Pharmaceuticals Price Performance Shares of CPIX stock opened at $2.02 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of […]
More Stories
GoDaddy (NYSE:GDDY) Earns “Buy” Rating from Benchmark
Benchmark reissued their buy rating on shares of GoDaddy (NYSE:GDDY – Free Report) in a report issued on Tuesday, Benzinga...
Wells Fargo & Company Cuts Rivian Automotive (NASDAQ:RIVN) Price Target to $11.00
Rivian Automotive (NASDAQ:RIVN – Free Report) had its target price decreased by Wells Fargo & Company from $15.00 to $11.00...
Wells Fargo & Company Boosts Rollins (NYSE:ROL) Price Target to $56.00
Rollins (NYSE:ROL – Free Report) had its target price raised by Wells Fargo & Company from $54.00 to $56.00 in...
Allstate (NYSE:ALL) Given New $216.00 Price Target at UBS Group
Allstate (NYSE:ALL – Free Report) had its price target lifted by UBS Group from $215.00 to $216.00 in a report...
Devon Energy (NYSE:DVN) Earns Hold Rating from Benchmark
Benchmark restated their hold rating on shares of Devon Energy (NYSE:DVN – Free Report) in a research note issued to...
Barclays Raises General Motors (NYSE:GM) Price Target to $64.00
General Motors (NYSE:GM – Free Report) (TSE:GMM.U) had its target price lifted by Barclays from $60.00 to $64.00 in a...